Corrigendum: Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy
Thomas Kyllo, Dominic Allocco, Laine Vande Hei, Heike Wulff, Jeffrey D. Erickson
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeuroscience and Neuropharmacology Research · Epilepsy research and treatment · Mitochondrial Function and Pathology
In the published article, the legend of Supplementary Figure S1 was mistakenly not included in the publication. The missing legend appears below:
“SUPPLEMENTARY FIGURE S1 Riluzole attenuates neural degeneration in the mediodorsal thalamus caused by KA-induced SE. Riluzole-treated rats showed less FJC labeling (green) than the KA group in the mediodorsal thalamus at 7 days (top row) and 14 days (bottom row). *Indicates the 3^rd^ ventricle. Low power (200x) and high power (400x) was captured using an exposure time of 400 ms. Scale bar = 200 μM for low power and 50 μM for high power.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.